Neisseria and Moraxella Species

Neisseria and Moraxella Species

Introduction to Neisseria Species

  • Gram Staining & Morphology

    • Neisseria species present as gram-negative diplococci on a gram stain.

    • Appearance includes shapes similar to kidney beans or coffee beans.

    • Misidentification possible if gram staining is inadequate, particularly with gram-positive cocci.

    • Important to specify gram negative diplococci rather than just gram negative cocci, as only clinically significant species are diplococci.

General Characteristics of Neisseria

  • Small size, non-motile organisms.

  • Biochemical Testing Initiation

    • Begin with the oxidase test: Neisseria species are oxidase positive.

  • Environmental Requirements

    • Capnophilic: Thrive in environments with 5-7% CO₂.

    • Require humidity for growth; normal flora in human and animal mucous membranes.

    • Pathogenic potential increased in immunosuppressed individuals.

Common Neisseria Species

  1. Neisseria gonorrhoeae

    • Always a pathogen.

  2. Neisseria meningitidis

    • May be commensal but can cause invasive disease (e.g., meningitis).

  3. Neisseria lactamica

    • Opportunistic pathogen.

  4. Neisseria sicca

    • Opportunistic pathogen.

  • Most of these species are normal flora in upper respiratory tract and genitourinary tract, acting as commensal organisms (benefit without harming the host).

Cultivation of Neisseria Species

  • Growth on sheep blood agar (except for N. gonorrhoeae, which grows poorly on this medium).

  • N. gonorrhoeae: Very small colonies on blood agar; better growth on chocolate agar.

  • Selective media developed for isolation:

    1. Modified Thayer Martin

      • Chocolate agar with vancomycin (inhibits gram positives), colistin (inhibits gram negatives), and nystatin (inhibits yeast) + trimethoprim (to inhibit Proteus).

    2. Martin Lewis agar

      • Similar to Thayer Martin but with increased vancomycin.

    3. New York City agar

      • Contains lysed horse blood and plasma, effective for mycoplasma isolation.

  • Incubation at body temperature, optimized for CO₂ levels.

  • Plates checked at intervals (24, 48, and 72 hours) for negative results.

Biochemical Testing

  • Oxidase Test: Essential for Neisseria, confirming oxidase positivity.

  • Superoxal Test: 30% hydrogen peroxide for rapid identification of N. gonorrhoeae; distinct bubbling indicates a reaction.

  • CTA Sugars Test:

    • Utilizes tubes with 1% of a singular carbohydrate (up to 5 tubes).

    • Incubation should prevent CO₂ influx to avoid false positives due to acidity.

    • Yellow color indicates acid production from carbohydrates, utilized for speciation.

    • Correlations of sugars with species:

      • N. gonorrhoeae: Positive for glucose.

      • N. meningitidis: Positive for glucose and maltose.

      • N. lactamica: Positive for lactose.

      • N. sicca: Positive for sucrose.

Virulence Factors of Neisseria Species

  • Receptors for transferrin: Aid in iron acquisition by breaking down lactoferrin.

  • Polysaccharide capsule: Prevents phagocytosis.

  • Outer membrane protein antigens: Mediate immune evasion.

  • IgA proteases: Neutralize mucosal antibodies, aiding infection establishment.

  • Pili: Facilitate attachment to host tissues; contribute to genetic exchange.

Neisseria gonorrhoeae Details

  • Pathogen in all encounters; primarily infected via sexual contact.

  • High infection rates in ages 20-24.

  • Causes gonorrhea, potentially leading to gonococcal arthritis and other complications.

  • Women can be asymptomatic; up to 50% risk in women versus 3-5% in men.

  • Infections can occur in multiple sites (vagina, endocervix, urethra, pharynx, anal canal).

  • Consequences for untreated infections: pelvic inflammatory disease, sterility, and ectopic pregnancy.

  • Gonococcal ophtymalia neonatorum: Infection in newborns from birth canal, preventable with treatment (silver nitrate, penicillin).

Collection and Transport of N. gonorrhoeae

  • Dacron/rayon swabs preferred; initiate plating within 6 hours of collection.

  • GEMBEC system: Maintains optimum growth conditions during transport, using modified Behr Martin or New York City agar.

Identification of N. gonorrhoeae

  • Confirmation via oxidase test, glucose positivity on CTA sugars, and various rapid tests (including MALDI TOF and nucleic acid tests).

  • Treatment: Current recommendation is ceftriaxone, often tested alongside Chlamydia trachomatis due to occurrence of co-infection.

Neisseria meningitidis Overview

  • Inhabitants of the human mucosal surfaces (nasopharynx, oropharynx).

  • Source for epidemic meningitis and meningococcemia, transmitted via respiratory droplets in close communities.

  • Typical onset of symptoms: stiff neck, fever, headaches.

  • Associated mortality rate of 25% even with treatment; individuals lacking certain immune factors at increased risk.

  • Waterhouse-Friedrichsen syndrome: A severe form due to adrenal failure associated with the infection.

Clinical Specimens for N. meningitidis

  • Cerebrospinal fluid, blood (avoid SPS in culture systems), nasopharyngeal swabs/aspirates essential.

  • Similar growth conditions to N. gonorrhoeae (blood agar, chocolate agar, CO₂ incubation).

Identification of N. meningitidis

  • Confirmed positive results via oxidase test; useful metabolic properties include glucose and maltose utilization.

  • Treatment of choice: penicillin, though susceptibility testing is usually irrelevant due to safety considerations.

  • Two vaccines available:

    1. Conjugated vaccine for group B strains, effective primarily in young adults.

    2. Quadrivalent conjugated vaccine for subtypes A, C, Y, and W135 for high-risk individuals.

Non-Pathogenic Neisseria Species

  1. Neisseria lactamica

    • Typically non-pathogenic; peaks in young children.

    • Utilizes lactose in carbohydrate tests.

  2. Neisseria sicca

    • Found in adult respiratory systems, oxidase positive; glucose, maltose, and sucrose utilization.

Moraxella catarrhalis Overview

  • Previously known as Neisseria catarrhalis; now a distinct Moraxella species.

  • Commensal in respiratory tract but can cause opportunistic infections.

  • Associated diseases: otitis media, sinusitis, and exacerbations in COPD patients.

Identification of Moraxella catarrhalis

  • Similar growth on blood and chocolate agar, but colony morphology resembles a hockey puck.

  • Differential Tests:

    • Butyrate esterase test: Positive for Moraxella, indicated by a blue color.

    • DNase Test: Indicates hydrolysis of DNA; Moraxella produces positive results.

    • Tributarine Test: Rapid test for presumptive identification based on butyrate esterase activity.

Antibiotic Therapy for Moraxella catarrhalis

  • Most isolates produce beta-lactamase, necessitating the use of alternative antibiotics like extended-spectrum cephalosporins, azithromycin, or fluoroquinolones.